Old barriers need not apply: Opening doors for new contraceptives in the developing world

摘要

New and improved methods of contraception have great potential for helping women in developing countries meet their family planning needs. These promising new methods include subcutaneous depo-medroxyprogesterone acetate (DMPA) in the Uniject?1 device (depo-subQ in Uniject) manufactured by Pfizer, Inc.; a low-cost two-rod levonor-gestrel-releasing implant [Sino-implant (II)] manufactured in China by Shanghai Dahua Pharmaceutical Co., Ltd.; and a levonorgestrel-releasing intrauterine system (LNG-IUS) similar to that manufactured by Bayer Healthcare Pharmaceuticals and currently marketed in the United States under the brand name Mirena~R